Cargando…
Immunomodulatory Strategies Targeting Dendritic Cells to Improve Corneal Graft Survival
Even though the cornea is regarded as an immune-privileged tissue, transplantation always comes with the risk of rejection due to mismatches between donor and recipient. It is common sense that an alternative to corticosteroids as the current gold standard for treatment of corneal transplantation is...
Autores principales: | Schönberg, Alfrun, Hamdorf, Matthias, Bock, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287922/ https://www.ncbi.nlm.nih.gov/pubmed/32354200 http://dx.doi.org/10.3390/jcm9051280 |
Ejemplares similares
-
Topical VEGF-C/D Inhibition Prevents Lymphatic Vessel Ingrowth into Cornea but Does Not Improve Corneal Graft Survival
por: Salabarria, Ann-Charlott, et al.
Publicado: (2020) -
Posttransplant VEGFR1R2 Trap Eye Drops Inhibit Corneal (Lymph)angiogenesis and Improve Corneal Allograft Survival in Eyes at High Risk of Rejection
por: Zhang, Wei, et al.
Publicado: (2022) -
Different Murine High-Risk Corneal Transplant Settings Vary Significantly in Their (Lymph)angiogenic and Inflammatory Cell Signatures
por: Zhang, Wei, et al.
Publicado: (2022) -
The role of the osmosensitive transcription factor NFAT5 in corneal edema resorption after injury
por: Hadrian, Karina, et al.
Publicado: (2023) -
Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation
por: Tahvildari, Maryam, et al.
Publicado: (2017)